TY - JOUR
T1 - Structure and function of L,D-and D,D-transpeptidase family enzymes from mycobacterium tuberculosis
AU - Tolufashe, Gideon F.
AU - Sabe, Victor T.
AU - Ibeji, Colins U.
AU - Ntombela, Thandokuhle
AU - Govender, Thavendran
AU - Maguire, Glenn E.M.
AU - Kruger, Hendrik G.
AU - Lamichhane, Gyanu
AU - Honarparvar, Bahareh
N1 - Funding Information:
We are grateful to the College of Health Sciences, UKZN, Aspen Pharmacare, Medical Research Council (MRC) and National Research Foundation (NRF), all in South Africa, for financial support.
Funding Information:
Gyanu Lamichhane was supported by NIH award R33AI111739. We would like to also acknowledge the editorial support of Ms. Martin Carrin.
Publisher Copyright:
© 2020 Bentham Science Publishers.
PY - 2020
Y1 - 2020
N2 - Peptidoglycan, the exoskeleton of bacterial cell and an essential barrier that protects the cell, is synthesized by a pathway where the final steps are catalysed by transpeptidases. Knowledge of the structure and function of these vital enzymes that generate this macromolecule in M. tuberculosis could facilitate the development of potent lead compounds against tuberculosis. This review summarizes the experimental and computational studies to date on these aspects of transpeptidases in M. tuberculosis that have been identified and validated. The reported structures of L,D- and D,D-transpeptidases, as well as their functionalities, are reviewed and the proposed enzymatic mechanisms for L,D-transpeptidases are summarized. In addition, we provide bioactivities of known tuberculosis drugs against these enzymes based on both experimental and computational approaches. Advancing knowledge about these prominent targets supports the development of new drugs with novel inhibition mechanisms overcoming the current need for new drugs against tuberculosis.
AB - Peptidoglycan, the exoskeleton of bacterial cell and an essential barrier that protects the cell, is synthesized by a pathway where the final steps are catalysed by transpeptidases. Knowledge of the structure and function of these vital enzymes that generate this macromolecule in M. tuberculosis could facilitate the development of potent lead compounds against tuberculosis. This review summarizes the experimental and computational studies to date on these aspects of transpeptidases in M. tuberculosis that have been identified and validated. The reported structures of L,D- and D,D-transpeptidases, as well as their functionalities, are reviewed and the proposed enzymatic mechanisms for L,D-transpeptidases are summarized. In addition, we provide bioactivities of known tuberculosis drugs against these enzymes based on both experimental and computational approaches. Advancing knowledge about these prominent targets supports the development of new drugs with novel inhibition mechanisms overcoming the current need for new drugs against tuberculosis.
KW - D,D-transpeptidase
KW - Drugs
KW - Enzymes
KW - L,D-transpeptidase
KW - Mycobacterium tuberculosis (Mtb)
KW - Peptidoglycan (PG)
UR - http://www.scopus.com/inward/record.url?scp=85086354573&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85086354573&partnerID=8YFLogxK
U2 - 10.2174/0929867326666181203150231
DO - 10.2174/0929867326666181203150231
M3 - Review article
C2 - 30501595
AN - SCOPUS:85086354573
SN - 0929-8673
VL - 27
SP - 3250
EP - 3267
JO - Current medicinal chemistry
JF - Current medicinal chemistry
IS - 19
ER -